內地疫情嚴峻本土病例再創新高 海底撈、九毛九及百勝中國跌逾3% 惟美團曾倒升逾7%
內地疫情持續擴散,新冠病例連續兩天突破2萬關,國家衛健委今天(7日)公布,內地昨天新增22,995宗本土新冠病例,包括1,284宗確診及21,711宗無症狀感染,再創疫情爆發以來單日新高,其中上海佔最多,新增19,982本土新冠病例。
於本港上市內地餐飲相關股今天以百勝中國-S(09987.HK)沽壓較大,股價兩連跌,今早失守10天及20天線,最低見328.6元,現報328.8元,續跌3.5%。
藍籌海底撈(06862.HK)沽壓較大,股價反覆(曾高見15.38元)失守10天線(14.8元),最低見14.76元,現報14.78元,回落3.3%。九毛九(09922.HK)三連跌,高低見16.16元/15.3元,現報15.36,反覆續跌3.2%。
於內地研發產銷火鍋與中式複合調味料的頤海國際(01579.HK)股價輕微高開後反覆受壓,最高見23.2元,現報21.75元即市低位,續跌1.8%。
內地最大連鎖酒館海倫司(09869.HK)反覆兩連跌,高低見13.78元/13.08元,現報13.16元,反覆續跌0.8%。奈雪的茶(02150.HK)反覆兩連跌,高低見4.84元/4.68元,現報4.74元,反覆續跌1%。
然而,獲大摩納入首選股名單的送餐股藍籌美團(03690.HK)承昨天回吐勢,今早再跌2%低見157.6元(接近10天線155.8元)獲承接,掉頭曾倒升逾7%高見172.5元遇阻,現報162.6元,倒升1.1%,成交已有1,884萬股。
於內地經營中式火鍋店的呷哺呷哺(00520.HK)今早股價平開報3.85元獲承接,掉頭曾漲約半成高見4.04元,現報3.88元,回升0.8%。
恆指繼昨天回吐近1.9%後,今早隨外圍在新經濟股主導低開170點或近0.8%報21,910獲承接,掉頭曾倒升156點或0.7%高見22,236無以為繼,現報21,908,續跌172點或0.8%,成交額514億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.